A New Understanding of the Migraine Chain Reaction
A study published this month in the journal Science is making headlines – and with reason. It may be a significant leap forward in understanding just how the migraine “chain-reaction” happens.
The study comes out of the University of Rochester and the University of Copenhagen, from researchers who have been studying fluids in the brain for many years. This particular study was with mice, which are commonly used to study the mechanics of migraine.
There are many things that we know about migraine, and many things that we don’t know. We’ve often talked, for example, about the “cortical spreading depression” (CSD), a kind of storm that sweeps across the brain, sometimes causing symptoms such as visual aura (when it passes by the “visual” part of the brain). The CSD is common in migraine.
We also know about some of the biology of headache, in nerves and their communication of pain.
But we know surprisingly little about how and why the brain communicates pain symptoms that are so disabling in a migraine attack. And that’s where the study may have found a key.
What researchers discovered had to do with the proteins in the body’s cerebrospinal fluid. Basically, neurons in the brain release certain proteins into this fluid, which transports them to the trigeminal ganglion, a bundle of nerves that affect the head and face.
Think of these proteins as messengers. Certain proteins will communicate “pain” to your nerves.
You may have already heard of one type of these proteins already – the calcitonin gene-related peptide (CGRP). CGRP has become all the rage in migraine treatment because of a host of new medications that have come out targeting CGRP levels.
But this study helps us understand just how the brain changes CGRP levels, and it also shows that there are other protein levels that are involved in migraine – perhaps in various types of migraine.
That means, of course, that researchers are looking to develop new medications that may target protein flow. Different types of medications may even be able to stop different types of migraine.
This initial study on mice is a long way from a new treatment, of course. But if the results continue to be confirmed by future studies, the information may go a long way toward helping us stop the flow of “pain messengers” to those nerves in your head.
For more information:
- Trigeminal ganglion neurons are directly activated by influx of CSF solutes in a migraine model (study abstract)
- Brain fluid dynamics key to migraine mysteries, new therapies (ScienceDaily)
- Pathway for Migraine with Aura Discovered (NeuroscienceNews.com)